Vnitr Lek 2009, 55(3):211-215

Antithrombotic prophylaxis during pregnancy

M. Penka1,*, P. Dulíček2, T. Binder3
1 Oddělení klinické hematologie FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Miroslav Penka, CSc.
2 Oddělení klinické hematologie II. interní kliniky Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.
3 Gynekologicko-porodnická klinika 2. lékařské fakulty UK a FN Motol Praha, přednosta doc. MUDr. Lukáš Rob, CSc.

Coagulation disturbances with their symptoms of thromboembolic - especially venous - disease play the most important role in the incidence of maternal mortality. The attention is focused on precise diagnostic procedures and on the treatment of all the disorders generally accompanied by coagulopathies. First-degree step is prevention of above mentioned complications, and the aim of its treatment is prevention of longterm complication or consequences. Actually is VTE resolved under the condition of the recommendation of 8th ACCP Conference.

Keywords: thrombosis; embolism; pregnancy; antithrombotic therapy; heparin

Received: February 5, 2009; Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Penka M, Dulíček P, Binder T. Antithrombotic prophylaxis during pregnancy. Vnitr Lek. 2009;55(3):211-215.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bates SM, Greer IA, Pabinger I et al. Venous thrombembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 2008; 133: 844S-886S. Go to original source...
    2. Binder T. Prevence trombembolické nemoci v těhotenství. Komentář. Gynekologie po promoci 2005; 1: 8-11.
    3. Buliková A, Crha I. Antifosfolipidové protilátky a antifosfolipidový syndrom v porodnictví. Prakt Gyn 2004; 1: 6-10.
    4. Chang J, Elam Evans LD, Berg CJ et al: Pregnancy-related mortality surveillance: United States, 1991-1999. MMWR Surveill Summ 2003; 52: 1-88.
    5. Dulíček P, Penka M, Binder T et al. Návrh antitrombotické profylaxe a péče o trombofilní stavy v gynekologii a porodnictví. Vnitř Lék 2006; 52 (S1): 58-40. Go to PubMed...
    6. Gherman RB, Goodwin TM, Leung B. Incidence, clinical characteristics, and Timing of objectively diagnose venous thrombembolism during pregnancy. Obstet Gynecol 1999; 94: 730-734. Go to original source... Go to PubMed...
    7. Ginsberg JS, Brill-Edwards P, Johnston M et al. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosis: a Gross-sectinal study. Blood 1992; 80: 975-980. Go to original source...
    8. Ginsberg JS, Greer IA, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001; 119 (Suppl 1): 122S-131S. Go to original source... Go to PubMed...
    9. Greer IA. Thrombosis in pregnancy: Maternal and fetal issues. Lancet 1999; 353: 1258-1265. Go to original source... Go to PubMed...
    10. Hirsh J. Guidelines for Antithrombotic Therapy. 8th ed. Hamilton: BC Decker Inc. 2008: 1-180.
    11. Janků K, Penka M. Gravidita při trvalé antikoagulační léčbě. Kardio 1988; 14: 46-51.
    12. Janků K, Penka M. Hyperkoagulační syndrom v těhotenství na podkladě defektu antitrombinu III. Čs gynek 1990; 55: 657-659.
    13. Kvasnička J. Trombofilie a trombotické stavy v klinické praxi. Praha: Grada Publishing 2003: 13-299.
    14. Penka M, Buliková A, Matýšková M et al. Diseminovaná intravaskulární koagulace (DIC). Praha: Grada Avicenum 2003: 9-231.
    15. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and leg of presentation. Obstet Gynecol Surv 1999; 54: 254-271. Go to original source...
    16. Widimský J, Malý J et al. Akutní plicní embolie a žilní trombóza. Praha Triton 2002, 7-303.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.